CRIS Current Research Information System

BARTOLETTI, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 782
EU - Europa 524
AS - Asia 324
AF - Africa 42
SA - Sud America 2
OC - Oceania 1
Totale 1.675
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 779
SG - Singapore 119
SE - Svezia 114
IT - Italia 104
CN - Cina 86
DE - Germania 81
GB - Regno Unito 76
IN - India 55
IE - Irlanda 43
VN - Vietnam 33
RU - Federazione Russa 24
TG - Togo 22
FR - Francia 21
FI - Finlandia 16
CI - Costa d'Avorio 13
CH - Svizzera 10
JO - Giordania 9
BE - Belgio 7
BG - Bulgaria 7
EE - Estonia 5
HK - Hong Kong 5
ID - Indonesia 5
NG - Nigeria 4
PL - Polonia 4
TR - Turchia 4
UA - Ucraina 4
CA - Canada 3
JP - Giappone 3
ZA - Sudafrica 3
AT - Austria 2
BR - Brasile 2
NL - Olanda 2
TW - Taiwan 2
AU - Australia 1
BD - Bangladesh 1
ES - Italia 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
PK - Pakistan 1
RO - Romania 1
Totale 1.675
Salva come PNG Salva come JPEG
Città #
Chandler 121
Singapore 110
Southend 69
Fairfield 64
Ashburn 51
Santa Clara 47
Dublin 43
Princeton 38
Dong Ket 32
Woodbridge 29
Boardman 26
Houston 26
Bologna 25
Wilmington 24
Seattle 23
Cambridge 22
Lomé 22
Hyderabad 21
Ann Arbor 17
Redmond 15
Helsinki 14
Abidjan 13
Milan 13
Nanjing 12
New York 12
Berlin 11
Bremen 11
Westminster 10
Amman 9
Bern 8
Turin 8
Brussels 7
Los Angeles 7
Sofia 7
Beijing 6
Des Moines 6
Boydton 5
Guangzhou 5
Jakarta 5
Munich 5
Redwood City 5
Saint Petersburg 5
San Diego 5
Abeokuta 4
Migliarino 4
Norwalk 4
Paris 4
Shenyang 4
Wenzhou 4
Bari 3
Changchun 3
Hong Kong 3
Mountain View 3
Olalla 3
Phoenix 3
San Francisco 3
Toronto 3
Wayne 3
Andover 2
Central 2
Cernusco sul Naviglio 2
Chicago 2
Falls Church 2
Fiesole 2
Harbin 2
Hefei 2
Imola 2
Jinan 2
Langfang 2
Lappeenranta 2
Mannheim 2
Modigliana 2
Poggio Renatico 2
Qingdao 2
Rome 2
Shijiazhuang 2
Taipei 2
Torino 2
Vienna 2
Warsaw 2
Abano Terme 1
Amsterdam 1
Bagnacavallo 1
Baoding 1
Bonn 1
Budapest 1
Bühl 1
Canberra 1
Capo D'orlando 1
Catanzaro 1
Charlotte 1
Chengdu 1
Clearwater 1
Cortona 1
Cutrofiano 1
Dearborn 1
Delhi 1
Dongguan 1
Faisalabad 1
Florence 1
Totale 1.129
Salva come PNG Salva come JPEG
Nome #
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib 145
Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients 145
Disease-specific derangement of circulating endocannabinoids and n-acylethanolamines in myeloproliferative neoplasms 137
Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis 133
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients 112
Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients 100
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis 85
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib. 79
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis 69
null 68
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data 68
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years. 66
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis 64
The diagnostic role of next generation sequencing in uncovering isolated splenomegaly: A case report 64
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 62
Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS-13 activity and autoantibodies 55
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia 46
Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID-19) pandemic: selection criteria and patients’ satisfaction 43
Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎ 38
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome 37
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis 26
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients 26
Longer-term response to SARS-CoV-2 vaccine in MPN patients: Role of ruxolitinib and disease severity 25
Spleen and Liver Fibrosis Is Associated to Treatment Response and Prognosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms 20
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome 19
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib 16
Immune Thrombocytopenia Onset and Relapse During the COVID-19 Pandemic. A Monocenter Study 15
Totale 1.763
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.926
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020124 0 0 0 0 0 20 23 28 22 13 11 7
2020/2021204 28 15 5 1 3 14 6 25 37 4 9 57
2021/2022349 5 13 13 33 25 18 8 32 16 31 91 64
2022/2023478 35 58 30 63 44 48 12 28 97 14 26 23
2023/2024173 9 38 18 18 14 22 2 14 4 15 8 11
2024/2025334 59 59 59 64 70 23 0 0 0 0 0 0
Totale 1.763